Search research articles
Contact Us
Filters
Showing results (91-100 of 145) with videos related to
Page
of 15
Sort By:
Cancer Research
|
June 11, 1999
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo
P A Hershberger, R A Modzelewski, Z R Shurin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
R J Bernardi, D L Trump, W D Yu, et al.
Investigational New Drugs
|
January 1, 1994
Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885
A Y Chang, Z N Tu, G T Bryan, et al.
American Journal of Clinical Oncology
|
April 25, 2001
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885
C Obasaju, J Manola, G R Hudes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1979
The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma
S B Baylin, T H Hsu, S A Stevens, et al.
Archives of Internal Medicine
|
October 1, 1985
Massive skeletal muscle invasion by lymphoma
J L Grem, A J Neville, S C Smith, et al.
Journal of Interferon Research
|
December 1, 1990
Biological and clinical effects of interferon-beta ser at two doses
E C Borden, J J Rinehart, B E Storer, et al.
The Journal of Urology
|
December 1, 1988
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study
N M Heney, W W Koontz, B Barton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects
D L Trump, K H Havlin, E M Messing, et al.
Cancer
|
January 15, 1986
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion
J M Koeller, D L Trump, K D Tutsch, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 145) with videos related to
Sort By:
Page
of 15
Cancer Research
|
June 11, 1999
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo
P A Hershberger, R A Modzelewski, Z R Shurin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
R J Bernardi, D L Trump, W D Yu, et al.
Investigational New Drugs
|
January 1, 1994
Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885
A Y Chang, Z N Tu, G T Bryan, et al.
American Journal of Clinical Oncology
|
April 25, 2001
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885
C Obasaju, J Manola, G R Hudes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1979
The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma
S B Baylin, T H Hsu, S A Stevens, et al.
Archives of Internal Medicine
|
October 1, 1985
Massive skeletal muscle invasion by lymphoma
J L Grem, A J Neville, S C Smith, et al.
Journal of Interferon Research
|
December 1, 1990
Biological and clinical effects of interferon-beta ser at two doses
E C Borden, J J Rinehart, B E Storer, et al.
The Journal of Urology
|
December 1, 1988
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study
N M Heney, W W Koontz, B Barton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects
D L Trump, K H Havlin, E M Messing, et al.
Cancer
|
January 15, 1986
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion
J M Koeller, D L Trump, K D Tutsch, et al.
Page
of 15